EXT2 exostosin glycosyltransferase 2 [Homo sapiens (human)] - Gene

Summary

Go to the top of the page Help

Official Symbol: EXT2provided by HGNC
Official Full Name: exostosin glycosyltransferase 2provided by HGNC
Primary source: HGNC:3513
See related: Ensembl:ENSG00000151348; HPRD:00599; MIM:608210; Vega:OTTHUMG00000166498
Gene type: protein coding
RefSeq status: REVIEWED
Organism: Homo sapiens
Lineage: Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo
Also known as: SOTV
Summary: This gene encodes one of two glycosyltransferases involved in the chain elongation step of heparan sulfate biosynthesis. Mutations in this gene cause the type II form of multiple exostoses. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jul 2008]

Genomic context

Go to the top of the page Help

Location :: 11p12-p11

Sequence :: Chromosome: 11; NC_000011.9 (44117099..44266980)

See EXT2 in Epigenomics, MapViewer

Chromosome 11 - NC_000011.9 Genomic Context describing neighboring genes

Genomic regions, transcripts, and products

Go to the top of the page Help

Genomic Sequence

Go to nucleotideGraphics FASTA GenBank

Go to reference sequence details

Bibliography

Go to the top of the page Help

GeneRIFs: Gene References Into Functions What's a GeneRIF?

20 novel EXT1/EXT2 mutations and one large EXT2 deletion identified in the largest Southern Italy cohort of patients affected by hereditary multiple exostosis.
Title: 20 novel point mutations and one large deletion in EXT1 and EXT2 genes: report of diagnostic screening in a large Italian cohort of patients affected by hereditary multiple exostosis.
A meta analysis indicates variation in the EXT2 locus appears to be associated with a small increase in the risk of type 2 diabetes.
Title: Association between variants of EXT2 and type 2 diabetes: a replication and meta-analysis.
analysis of novel pathogenic mutations in EXT1 and EXT2 that may have roles in multiple osteochondroma in Chinese patients
Title: Mutation screening of EXT genes in Chinese patients with multiple osteochondromas.
Two novel EXT1 gene mutations were identified and no mutation was found in EXT2 gene in two families with multiple osteochodromas.
Title: Mutation analysis and prenatal diagnosis of EXT1 gene mutations in Chinese patients with multiple osteochondromas.
Fifteen mutations and large deletions, of which nine are new, were detected in the EXT1 and EXT2 gene by sequence analysis, FISH and MLPA analysis.
Title: Clinical and molecular studies of EXT1/EXT2 in Bulgaria.
Association of genetic variations in EXT2 with Type 2 diabetes mellitus in Tunisia
Title: Association of genetic variations in TCF7L2, SLC30A8, HHEX, LOC387761, and EXT2 with Type 2 diabetes mellitus in Tunisia.
Molecular characterization of EXT1- and EXT2-deletion breakpoints in multiple osteochondroma indicates that non-allelic homologous recombination between Alu-sequences as well as NHEJ are causal and that the majority of these deletions are nonrecurring.
Title: Breakpoint characterization of large deletions in EXT1 or EXT2 in 10 multiple osteochondromas families.
8 novel mutations of EXT1 and EXT2 genes among families and sporadic cases with multiple exostoses were identified.
Title: Novel mutations of EXT1 and EXT2 genes among families and sporadic cases with multiple exostoses.
Loss of heterozygosity for EXT2 is associated with multiple osteochondromas.
Title: No haploinsufficiency but loss of heterozygosity for EXT in multiple osteochondromas.
Observational study of gene-disease association, gene-gene interaction, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)
Title: Impact of single nucleotide polymorphisms and of clinical risk factors on new‐onset diabetes mellitus in HIV‐infected individuals.

Submit: New GeneRIF Correction See all (38)

Phenotypes

Go to the top of the page Help

Find tests for this gene in the NIH Genetic Testing Registry (GTR)

Review eQTL and phenotype association data in this region using PheGenI

Hereditary multiple exostoses, type II

MIM: 133701

Genetic Testing Registry

Summary from GeneReviews: Hereditary Multiple Osteochondromas

The disorder hereditary multiple osteochondromas (HMO), previously called hereditary multiple exostoses (HME), is characterized by growths of multiple osteochondromas (benign cartilage-capped bone tumors that grow outward from the metaphyses of long bones). Osteochondromas can be associated with a reduction in skeletal growth, bony deformity, restricted joint motion, shortened stature, premature osteoarthrosis, and compression of peripheral nerves. The median age of diagnosis is three years; nearly all affected individuals are diagnosed by age 12 years. The risk for malignant degeneration to osteochondrosarcoma increases with age, although the lifetime risk of malignant degeneration is low (~1%).

Diagnosis Testing

The diagnosis of HMO is based on clinical and/or radiographic findings of multiple exostoses in one or more members of a family. The two genes known to be associated with HMO are EXT1 and EXT2; a third locus is possible. A combination of sequence analysis and deletion analysis of the entire coding regions of both EXT1 and EXT2 detects mutations in 70%-95% of affected individuals.

Genetic Counseling

HMO is inherited in an autosomal dominant manner. Penetrance is approximately 96%. Ten percent of affected individuals have HMO as the result of a de novo mutation. Offspring of an affected individual have a 50% risk of inheriting the disease-causing mutation. Prenatal testing for pregnancies at increased risk is possible if the disease-causing mutation in a family is known.

References

PMID: 20301413

Interactions

Go to the top of the page Help

Products	Interactant	Other Gene	Source	Pubs	Description
Q93063	Q16394	EXT1	HPRD	PubMed
Q93063	Q93063	EXT2	HPRD	PubMed
Q93063	Q7Z7M9	GALNT5	HPRD	PubMed
Q93063	Q12931	TRAP1	HPRD	PubMed
BioGRID:108433	BioGRID:106807	ANXA7	BioGRID	PubMed	Two-hybrid
BioGRID:108433	BioGRID:107460	CDKN1A	BioGRID	PubMed	Two-hybrid
BioGRID:108433	BioGRID:127555	CLEC2L	BioGRID	PubMed	Affinity Capture-MS
BioGRID:108433	BioGRID:107670	CNTF	BioGRID	PubMed	Affinity Capture-MS
BioGRID:108433	BioGRID:116990	CRB1	BioGRID	PubMed	Affinity Capture-MS
BioGRID:108433	BioGRID:108432	EXT1	BioGRID	PubMed	Affinity Capture-Western
BioGRID:108433	BioGRID:108433	EXT2	BioGRID	PubMed	Affinity Capture-Western
BioGRID:108433	BioGRID:108465	FABP4	BioGRID	PubMed	Affinity Capture-MS
BioGRID:108433	BioGRID:116394	GALNT5	BioGRID	PubMed	Reconstituted Complex; Two-hybrid
BioGRID:108433	BioGRID:119589	GSKIP	BioGRID	PubMed	Two-hybrid
BioGRID:108433	BioGRID:109414	HNF4A	BioGRID	PubMed	Affinity Capture-MS
BioGRID:108433	BioGRID:115780	HYOU1	BioGRID	PubMed	Affinity Capture-MS
BioGRID:108433	BioGRID:111223	PFDN1	BioGRID	PubMed	Two-hybrid
BioGRID:108433	BioGRID:112149	RPS29	BioGRID	PubMed	Affinity Capture-MS
BioGRID:108433	BioGRID:112469	SLC22A2	BioGRID	PubMed	Two-hybrid
BioGRID:108433	BioGRID:112490	SMN1	BioGRID	PubMed	Two-hybrid
BioGRID:108433	BioGRID:112507	SNCG	BioGRID	PubMed	Affinity Capture-MS
BioGRID:108433	BioGRID:114144	STK16	BioGRID	PubMed	Affinity Capture-MS
BioGRID:108433	BioGRID:112783	TCEB1	BioGRID	PubMed	Affinity Capture-MS
BioGRID:108433	BioGRID:112938	TK1	BioGRID	PubMed	Two-hybrid
BioGRID:108433	BioGRID:115435	TRAP1	BioGRID	PubMed	Reconstituted Complex; Two-hybrid
BioGRID:108433	BioGRID:113164	UBC	BioGRID	PubMed	Affinity Capture-MS

Pathways from BioSystems

Go to the top of the page Help

Disease, organism-specific biosystem (from REACTOME)
Disease, organism-specific biosystemBiological processes are captured in Reactome by identifying the molecules (DNA, RNA, protein, small molecules) involved in them and describing the details of their interactions. From this molecular ...
Glycosaminoglycan biosynthesis - heparan sulfate / heparin, organism-specific biosystem (from KEGG)
Glycosaminoglycan biosynthesis - heparan sulfate / heparin, organism-specific biosystemHeparan sulfate (HS) and heparin (Hep) are glycosaminoglycans with repeating disaccharide units that consist of alternating residues of alpha-D-glucosamine (GlcN) and uronic acid, the latter being ei...
Glycosaminoglycan biosynthesis - heparan sulfate / heparin, conserved biosystem (from KEGG)
Glycosaminoglycan biosynthesis - heparan sulfate / heparin, conserved biosystemHeparan sulfate (HS) and heparin (Hep) are glycosaminoglycans with repeating disaccharide units that consist of alternating residues of alpha-D-glucosamine (GlcN) and uronic acid, the latter being ei...
Glycosaminoglycan biosynthesis, heparan sulfate backbone, organism-specific biosystem (from KEGG)
Glycosaminoglycan biosynthesis, heparan sulfate backbone, organism-specific biosystemPathway module; Carbohydrate and lipid metabolism; Glycosaminoglycan metabolism
Glycosaminoglycan biosynthesis, heparan sulfate backbone, conserved biosystem (from KEGG)
Glycosaminoglycan biosynthesis, heparan sulfate backbone, conserved biosystemPathway module; Carbohydrate and lipid metabolism; Glycosaminoglycan metabolism
Glycosaminoglycan metabolism, organism-specific biosystem (from REACTOME)
Glycosaminoglycan metabolism, organism-specific biosystemGlycosaminoglycans (GAGs) are long, unbranched polysaccharides containing a repeating disaccharide unit composed of a hexosamine (either N-acetylgalactosamine (GalNAc) or N-acetylglucosamine (GlcNAc)...
HS-GAG biosynthesis, organism-specific biosystem (from REACTOME)
HS-GAG biosynthesis, organism-specific biosystemHeparan sulfate (HS) and heparin (sometimes collectively called HS-GAG) consist of the disaccharide unit GlcNAc-GlcA (N-acetylglucosamine-glucuronic acid) connected by a beta1,4 linkage. Heparin is e...
Heparan sulfate/heparin (HS-GAG) metabolism, organism-specific biosystem (from REACTOME)
Heparan sulfate/heparin (HS-GAG) metabolism, organism-specific biosystemThe acronym HS-GAG is used to describe both heparin and heparan sulfate. HS-GAG is a member of the glycosaminoglycan family and consists of a variably sulfated repeating disaccharide unit, the most ...
MPS I - Hurler syndrome, organism-specific biosystem (from REACTOME)
MPS I - Hurler syndrome, organism-specific biosystemMucopolysaccharidosis type I (MPS I, Hurler syndrome, Hurler's disease, gargoylism, Scheie, Hirler-Scheie syndrome; MIM:607014, 607015 and 607016) is an autosomal recessive genetic disorder where th...
MPS II - Hunter syndrome, organism-specific biosystem (from REACTOME)
MPS II - Hunter syndrome, organism-specific biosystemMucopolysaccharidosis II (MPS II, Hunter syndrome, MIM:309900) is an X-linked, recessive genetic disorder which therefore primarily affects males. MPS II was first described in 1917, by Major Charles...
MPS IIIA - Sanfilippo syndrome A, organism-specific biosystem (from REACTOME)
MPS IIIA - Sanfilippo syndrome A, organism-specific biosystemMucopolysaccharidosis III (MPS III, Sanfilippo syndrome) was described in 1963 by a pediatrician named Sylvester Sanfilippo (J. Pediat. 63: 837-838, 1963, no reference). Mucopolysaccharidosis IIIA (M...
MPS IIIB - Sanfilippo syndrome B, organism-specific biosystem (from REACTOME)
MPS IIIB - Sanfilippo syndrome B, organism-specific biosystemMucopolysaccharidosis III (Sanfilippo syndrome) was described in 1963 by a pediatrician named Sylvester Sanfilippo (J. Pediat. 63: 837838, 1963, no reference). MPS IIIB (Mucopolysaccharidosis type II...
MPS IIIC - Sanfilippo syndrome C, organism-specific biosystem (from REACTOME)
MPS IIIC - Sanfilippo syndrome C, organism-specific biosystemMucopolysaccharidosis III (Sanfilippo syndrome) was described in 1963 by a pediatrician named Sylvester Sanfilippo (J. Pediat. 63: 837838, 1963, no reference). Mucopolysaccharidosis type IIIC (MPS II...
MPS IIID - Sanfilippo syndrome D, organism-specific biosystem (from REACTOME)
MPS IIID - Sanfilippo syndrome D, organism-specific biosystemMucopolysaccharidosis III (Sanfilippo syndrome) was described in 1963 by a pediatrician named Sylvester Sanfilippo (J. Pediat. 63: 837-838, 1963, no reference). Mucopolysaccharidosis type IIID (MPS I...
MPS IV - Morquio syndrome A, organism-specific biosystem (from REACTOME)
MPS IV - Morquio syndrome A, organism-specific biosystemMucopolysaccharidosis IV A (MPS IVA, MPS4A, Morquio's syndrome, Morquio's; MIM:253000) is a rare, autosomal recessive mucopolysaccharide storage disease, first described simultaneously in 1929 by L M...
MPS IV - Morquio syndrome B, organism-specific biosystem (from REACTOME)
MPS IV - Morquio syndrome B, organism-specific biosystemDefects in beta-galactosidase (GLB1; MIM:611458) can result in GM1 gangliosidosis (GM1; MIM:230500) (Nishimoto et al. 1991) (not described here), with several phenotypes indicating mental deteriorati...
MPS IX - Natowicz syndrome, organism-specific biosystem (from REACTOME)
MPS IX - Natowicz syndrome, organism-specific biosystemMucopolysaccharidosis type IX (MPS IX, Natowicz syndrome, Hyaluronidase deficiency, MIM:601492) is a rare lysosomal storage disease characterized by high hyaluronan (HA) concentration in the serum re...
MPS VI - Maroteaux-Lamy syndrome, organism-specific biosystem (from REACTOME)
MPS VI - Maroteaux-Lamy syndrome, organism-specific biosystemMucopolysaccharidosis type VI (MPS VI, Maroteaux-Lamy syndrome, polydystrophic dwarfism; MIM:253200) is an autosomal recessive lysosomal storage disorder caused by a deficiency in arylsulfatase B (AR...
MPS VII - Sly syndrome, organism-specific biosystem (from REACTOME)
MPS VII - Sly syndrome, organism-specific biosystemMucopolysaccharidosis type VII (MPS VII, Sly syndrome, beta-glucuronidase deficiency; MIM:253220) is an autosomal recessive lysosomal storage disease characterized by a deficiency of the enzyme beta-...
Metabolism, organism-specific biosystem (from REACTOME)
Metabolism, organism-specific biosystemMetabolic processes in human cells generate energy through the oxidation of molecules consumed in the diet and mediate the synthesis of diverse essential molecules not taken in the diet as well as th...
Metabolism of carbohydrates, organism-specific biosystem (from REACTOME)
Metabolism of carbohydrates, organism-specific biosystemThese pathways together are responsible for: 1) the extraction of energy and carbon skeletons for biosyntheses from dietary sugars and related molecules; 2) the short-term storage of glucose in the b...
Mucopolysaccharidoses, organism-specific biosystem (from REACTOME)
Mucopolysaccharidoses, organism-specific biosystemThe mucopolysaccharidoses (MPS) are a group of rare, inherited lysosomal storage disorders caused by deficiencies of enzymes catalyzing the stepwise degradation of glycosaminoglycans (GAGs, originall...
heparan sulfate biosynthesis, organism-specific biosystem (from BIOCYC)
heparan sulfate biosynthesis, organism-specific biosystem
heparan sulfate biosynthesis
heparan sulfate biosynthesis, conserved biosystem (from BIOCYC)
heparan sulfate biosynthesis, conserved biosystemBackground |FRAME: Heparan-Sulfate "Heparan sulfate"| is a linear polysaccharide found in all animal tissues. It occurs as a proteoglycan in which two or three heparan sulfate chains are attached to...
heparan sulfate biosynthesis (late stages), organism-specific biosystem (from BIOCYC)
heparan sulfate biosynthesis (late stages), organism-specific biosystemBackground : Heparan-Sulfate "Heparan sulfate" is a linear polysaccharide found in all animal tissues. It occurs as a proteoglycan in which two or three heparan sulfate chains are attached to cell s...
heparan sulfate biosynthesis (late stages), conserved biosystem (from BIOCYC)
heparan sulfate biosynthesis (late stages), conserved biosystemBackground |FRAME: Heparan-Sulfate "Heparan sulfate"| is a linear polysaccharide found in all animal tissues. It occurs as a proteoglycan in which two or three heparan sulfate chains are attached to...

General gene information

Go to the top of the page Help

Markers

HSC1YH092 (e-PCR)
- UniSTS:80896

D11S2263E (e-PCR)
- UniSTS:78861

RH45722 (e-PCR)
- UniSTS:48141

D11S4650 (e-PCR)
- UniSTS:37912

D11S903 (e-PCR), detects polymorphism
- UniSTS:2601

RH121355 (e-PCR)
- UniSTS:134201

WI-20248 (e-PCR)
- UniSTS:72780

SHGC-149810 (e-PCR)
- UniSTS:177234

D11S3975 (e-PCR)
- UniSTS:74589

D11S903 (e-PCR), detects polymorphism
- UniSTS:14215

RH98305 (e-PCR)
- UniSTS:84618

STS-N22755 (e-PCR)
- UniSTS:47793

D11S3805 (e-PCR)
- UniSTS:153035

GDB:313855 (e-PCR)
- UniSTS:56811

Genotypes

See EXT2 SNP Geneview Report
See EXT2 SNP Genotype Report
See EXT2 SNP Variation Viewer Report

Homology

Homologs of the EXT2 gene: The EXT2 gene is conserved in chimpanzee, Rhesus monkey, dog, cow, mouse, rat, chicken, zebrafish, fruit fly, and mosquito.
Map Viewer (Mouse, Rat)
OrthoDB: The Hierarchical Catalog of Eukaryotic Orthologs

Gene Ontology Provided by GOA

Function	Evidence Code	Pubs
N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity	NAS Non-traceable Author Statement more info	PubMed
contributes_to acetylglucosaminyltransferase activity	IDA Inferred from Direct Assay more info	PubMed
glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity	IEA Inferred from Electronic Annotation more info
glucuronosyltransferase activity	IDA Inferred from Direct Assay more info	PubMed
heparan sulfate N-acetylglucosaminyltransferase activity	NAS Non-traceable Author Statement more info	PubMed
protein heterodimerization activity	IPI Inferred from Physical Interaction more info	PubMed
NOT protein homodimerization activity	IDA Inferred from Direct Assay more info	PubMed
transferase activity, transferring glycosyl groups	IDA Inferred from Direct Assay more info	PubMed

Process	Evidence Code	Pubs
carbohydrate metabolic process	TAS Traceable Author Statement more info
cellular polysaccharide biosynthetic process	IDA Inferred from Direct Assay more info	PubMed
glycosaminoglycan biosynthetic process	IDA Inferred from Direct Assay more info	PubMed
glycosaminoglycan biosynthetic process	TAS Traceable Author Statement more info
glycosaminoglycan metabolic process	TAS Traceable Author Statement more info
heparan sulfate proteoglycan biosynthetic process	IMP Inferred from Mutant Phenotype more info	PubMed
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process	IMP Inferred from Mutant Phenotype more info	PubMed
ossification	IMP Inferred from Mutant Phenotype more info	PubMed
protein glycosylation	IEA Inferred from Electronic Annotation more info
signal transduction	TAS Traceable Author Statement more info	PubMed
small molecule metabolic process	TAS Traceable Author Statement more info

Component	Evidence Code	Pubs
Golgi apparatus	ISS Inferred from Sequence or Structural Similarity more info
Golgi membrane	TAS Traceable Author Statement more info
endoplasmic reticulum	ISS Inferred from Sequence or Structural Similarity more info
endoplasmic reticulum membrane	TAS Traceable Author Statement more info	PubMed
integral to membrane	IEA Inferred from Electronic Annotation more info
intrinsic to endoplasmic reticulum membrane	IEA Inferred from Electronic Annotation more info

General protein information

Go to the top of the page Help

Preferred Names: exostosin-2

Names: exostosin-2; exostosin 2; multiple exostoses protein 2; putative tumor suppressor protein EXT2; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase; glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase

NP_000392.3

EC 2.4.1.224

EC 2.4.1.225

NP_001171554.1

EC 2.4.1.224

EC 2.4.1.225

NP_997005.1

EC 2.4.1.224

EC 2.4.1.225

NCBI Reference Sequences (RefSeq)

Go to the top of the page Help

RefSeqs maintained independently of Annotated Genomes

These reference sequences exist independently of genome builds. Explain

These reference sequences are curated independently of the genome annotation cycle, so their versions may not match the RefSeq versions in the current genome build. Identify version mismatches by comparing the version of the RefSeq in this section to the one reported in Genomic regions, transcripts, and products above.

Genomic

NG_007560.1 RefSeqGene

Range

5001..154882

Download

GenBank, FASTA, Sequence Viewer (Graphics)

mRNA and Protein(s)

NM_000401.3 → NP_000392.3 exostosin-2 isoform 1

Status: REVIEWED

Description

Transcript Variant: This variant (1) encodes the longer isoform (1).

Source sequence(s)

AC068457, AC103854, BE348865, BX648142, DA738392

Consensus CDS

CCDS53618.1

UniProtKB/Swiss-Prot

Q93063

Related

ENSP00000379032, ENST00000395673

Conserved Domains (2) summary

pfam09258
Location:489 – 734
Blast Score: 958

Glyco_transf_64; Glycosyl transferase family 64 domain

pfam03016
Location:133 – 413
Blast Score: 565

Exostosin; Exostosin family
NM_001178083.1 → NP_001171554.1 exostosin-2 isoform 3

Status: REVIEWED

Description

Transcript Variant: This variant (3) has multiple differences, compared to variant 1. These differences result in a distinct 5' UTR and cause translation initiation at a downstream start codon, compared to variant 1. The encoded protein (isoform 3) is shorter than isoform 1.

Source sequence(s)

AC068457, AC103854, BE348865, BX648142, U62740, U72263

Consensus CDS

CCDS53619.1

UniProtKB/Swiss-Prot

Q93063

Related

ENSP00000351509, OTTHUMP00000233077, ENST00000358681, OTTHUMT00000390073

Conserved Domains (2) summary

pfam09258
Location:466 – 711
Blast Score: 952

Glyco_transf_64; Glycosyl transferase family 64 domain

pfam03016
Location:100 – 380
Blast Score: 562

Exostosin; Exostosin family
NM_207122.1 → NP_997005.1 exostosin-2 isoform 2

Status: REVIEWED

Description

Transcript Variant: This variant (2) is the predominant transcript and differs in the 5' UTR and coding region, compared to variant 1. These differences causes translation initiation at a downstream start codon and result in isoform (2) which has a shorter N-terminus, compared to isoform 1.

Source sequence(s)

BM997250, U62740

Consensus CDS

CCDS7908.1

UniProtKB/Swiss-Prot

Q93063

Related

ENSP00000431173, OTTHUMP00000233074, ENST00000533608, OTTHUMT00000390069

Conserved Domains (2) summary

pfam09258
Location:456 – 701
Blast Score: 953

Glyco_transf_64; Glycosyl transferase family 64 domain

pfam03016
Location:100 – 380
Blast Score: 563

Exostosin; Exostosin family

RefSeqs of Annotated Genomes: Homo sapiens Annotation Release 104

The following sections contain reference sequences that belong to a specific genome build. Explain

Reference GRCh37.p10 Primary Assembly

Genomic

NC_000011.9 Reference GRCh37.p10 Primary Assembly

Range

44117099..44266980

Download

GenBank, FASTA, Sequence Viewer (Graphics)

Alternate HuRef

Genomic

AC_000143.1 Alternate HuRef

Range

43826189..43975955

Download

GenBank, FASTA, Sequence Viewer (Graphics)

Alternate CHM1_1.0

Genomic

NC_018922.1 Alternate CHM1_1.0

Range

44045392..44195211

Download

GenBank, FASTA, Sequence Viewer (Graphics)

Nucleotide		Protein
Heading	Accession and Version	Protein
genomic	ABBA01060770.1 (409123..485703)	None
genomic	ABBA01060771.1	None
genomic	AC068457.5 (77528..142403)	None
genomic	AC103854.2 (90653..152529)	None
genomic	AC134775.8	None
genomic	AMYH01003522.1 (152705..302524)	None
genomic	CH471064.2	EAW68067.1
		EAW68068.1
		EAW68069.1
		EAW68070.1
		EAW68071.1
genomic	U67354.1 (152..248)	None
genomic	U67355.1 (329..384)	None
genomic	U67368.1	AAC51219.1
mRNA	AK296713.1	BAH12417.1
mRNA	AK309459.1	None
mRNA	AK312375.1	BAG35293.1
mRNA	BC010058.1	AAH10058.1
mRNA	BC013050.1	None
mRNA	BC068545.1	AAH68545.1
mRNA	BE348865.1	None
mRNA	BM997250.1	None
mRNA	BX648142.1	None
mRNA	DA738392.1	None
mRNA	U62740.1	AAB07008.1
mRNA	U64511.1	AAC50764.1
mRNA	U72263.1	AAB62718.1
other-genetic	JF432315.1	ADZ15532.1